1-[N-(4-BIPHENYLYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER
Compound with spectra: 1 NMR
![1-[N-(4-BIPHENYLYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER](/api/compound/1gd43gA2KEj.png?ph=true&h=300&w=458 "1-[N-(4-BIPHENYLYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER")
| SpectraBase Compound ID | 1gd43gA2KEj |
|---|---|
| InChI | InChI=1S/C34H42N4O5/c1-2-42-32(39)18-17-31(36-34(41)43-26-28-9-5-3-6-10-28)33(40)35-19-20-37-21-23-38(24-22-37)25-27-13-15-30(16-14-27)29-11-7-4-8-12-29/h3-16,31H,2,17-26H2,1H3,(H,35,40)(H,36,41)/t31-/m1/s1 |
| InChIKey | ICMCFQDYOQYHEL-WJOKGBTCSA-N |
| Mol Weight | 586.7 g/mol |
| Molecular Formula | C34H42N4O5 |
| Exact Mass | 586.31552 g/mol |
| Enantiomer InChIKey | ICMCFQDYOQYHEL-HKBQPEDESA-N |
| Racemate InChIKey | ICMCFQDYOQYHEL-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
L-N-[N-(N-CARBOXY-L-LEUCYL)GLYCYL]LEUCINE, DIBENZYL ESTER
benzyl (1S)-1-({[(1S)-1-(aminocarbonyl)-3-(methylsulfanyl)propyl]amino}carbonyl)-2-methylbutylcarbamate
WZUPFUJAVKNMDS-UHFFFAOYSA-N
N-Carbobenzoxyleucyl-leucyl-leucyl-leucyl-leucine
(2S)-2-[[(2S)-2-[[(2S)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoic acid
benzyl (1S)-1-({[(1S)-2-amino-1-benzyl-2-oxoethyl]amino}carbonyl)-3-(methylsulfanyl)propylcarbamate
N-[(N-CARBOXY-L-alpha-GLUTAMYL)OXY]SUCCINIMIDE, N-BENZYL tert-BUTYLESTER
Alaninamide, N-[(phenylmethoxy)carbonyl]-L-phenylalanyl-N,N,2-trimethyl-
L-(-)-N-(N-CARBOXY-L-ISOLEUCYL)METHIONINE, N-BENZYL ESTER
METHYL-N-(BENZYLOXYCARBONYL)-ISOLEUCYLALANYLALANINE
| Title | Journal or Book | Year |
|---|---|---|
| Lipase-catalysed synthesis of new acetylcholinesterase inhibitors: N-benzylpiperidine aminoacid derivatives | Bioorganic & Medicinal Chemistry | 2000 |